PWP News and Resources
Family History Of Melanoma Linked To Parkinson’s Disease
ScienceDaily / Feb. 16, 2009
People with a family history of melanoma may have a greater risk of developing Parkinson’s disease. The study involved nearly 157,000 people who did not have Parkinson’s disease. They were asked if their parents or siblings had been diagnosed with melanoma, the deadliest form of skin cancer. Researchers then traced their progress for a period of 14 to 20 years. During that time, 616 of the people were diagnosed with Parkinson’s disease.
Depomed Initiates Phase I Trial for DM-1992 Program in Parkinson’s Disease Following Positive Results of Preclinical Studies Sponsored by The Michael J. Fox Foundation
CentralDaily.com / Tuesday, Feb. 17, 2009
MENLO PARK, Calif. — Depomed, Inc. (NASDAQ / DEPO) today announced that it has dosed the first patient in a Phase I trial for its DM-1992 program in Parkinson’s disease based on positive results from preclinical studies sponsored by The Michael J. Fox Foundation for Parkinson’s Research. DM-1992 is an investigative novel gastric retentive extended-release dosage form of Levodopa/Carbidopa, a marketed therapy used in the treatment of Parkinson’s disease.
Click above to find the source